Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 11:31 AM ET

Date/Time Source News Release
04/29/2025 08:00 AM EDT GlobeNewswire Annovis Bio Appoints Hui Liu as Director of Biostatistics
03/27/2025 04:30 PM EDT GlobeNewswire Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
03/25/2025 08:00 AM EDT GlobeNewswire Annovis to Attend AD/PD(TM) 2025 with Extensive Scientific Program
03/21/2025 05:05 PM EDT GlobeNewswire Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
03/11/2025 08:00 AM EDT GlobeNewswire Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
02/19/2025 08:30 AM EST GlobeNewswire Annovis to Host Patients' Live Forum on February 27, 2025
02/07/2025 08:00 AM EST GlobeNewswire Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
02/05/2025 08:00 AM EST GlobeNewswire Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease
02/04/2025 04:31 PM EST GlobeNewswire Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
02/03/2025 06:22 AM EST GlobeNewswire Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
Page

Additional News

As of April 30, 2025 • 11:31 AM ET

Date/Time Source News Release
04/29/2025 09:35 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
03/28/2025 08:50 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Receives NYSE Noncompliance Notice Over Market Cap and Equity Levels
03/27/2025 04:45 PM EDT SeekingAlpha Annovis Bio receives NYSE notice over non-compliance with listing rules
03/25/2025 10:28 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Present Late-Stage Alzheimer's and Parkinson's Data at AD/PD 2025 
03/24/2025 09:05 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Advances Alzheimer's and Parkinson's Pipeline, Launches Pivotal Phase 3 Trial
03/21/2025 05:17 PM EDT SeekingAlpha Annovis Bio GAAP EPS of -$0.43 misses by $0.13
03/14/2025 11:05 AM EDT InvestorBrandNetwork The Brain's 'Cleanup Crew' Could Hold the Key to Alzheimer's Treatment, Study Shows
03/11/2025 10:43 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Present at Alzheimer's & Parkinson's Drug Development Summit 
03/04/2025 10:05 AM EST InvestorBrandNetwork Scientists Say Brain Stimulations Hold Potential in Treating Anxiety in Parkinson's Sufferers
02/19/2025 10:44 AM EST InvestorBrandNetwork BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Host Patient Forum on Alzheimer's and Parkinson's Trials
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.